Sarissa Capital Management LP Long-Term Concentrated

CIK: 0001577524 · Show all filings

Period: Q4 2013 (Next →)

Filing Date: Feb 14, 2014

Total Value ($000): $267,017 (100.0% shares, 0.0% debt)

Holdings (12)

— ARIAD PHARMACEUTICALS INC 30.6%

Value ($000) $81,840 Shares 12,000,000 Est. Cost $6.82 Unrealized —

DGX QUEST DIAGNOSTICS INC 14.0%

Value ($000) $37,478 Shares 700,000 Est. Cost $46.46 Unrealized 0.0%

— IDENIX PHARMACEUTICALS INC 11.3%

Value ($000) $30,200 Shares 5,050,100 Est. Cost $5.98 Unrealized —

— VIVUS INC 8.8%

Value ($000) $23,371 Shares 2,573,943 Est. Cost $9.08 Unrealized —

MRK MERCK & CO INC NEW 7.5%

Value ($000) $20,020 Shares 400,000 Est. Cost $31.29 Unrealized 0.0%

— MALLINCKRODT PUB LTD CO 5.5%

Value ($000) $14,633 Shares 280,000 Est. Cost $52.26 Unrealized —

BMY BRISTOL MYERS SQUIBB CO 5.0%

Value ($000) $13,288 Shares 250,000 Est. Cost $34.16 Unrealized 0.0%

ABBV ABBVIE INC 4.9%

Value ($000) $13,203 Shares 250,000 Est. Cost $30.39 Unrealized 0.0%

PFE PFIZER INC 4.7%

Value ($000) $12,558 Shares 410,000 Est. Cost $17.62 Unrealized 0.0%

— REPROS THERAPEUTICS INC 3.1%

Value ($000) $8,409 Shares 459,508 Est. Cost $18.30 Unrealized —

— BIO-REFERENCE LABS INC 2.7%

Value ($000) $7,287 Shares 285,300 Est. Cost $25.54 Unrealized —

— AVEO PHARMACEUTICALS 1.8%

Value ($000) $4,730 Shares 2,570,759 Est. Cost $1.84 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ARIAD PHARMACEUTICALS INC	12,000,000	$81,840	30.6%	$6.82	—	COM	04033A100
DGX	QUEST DIAGNOSTICS INC	700,000	$37,478	14.0%	$46.46	0.0%	COM	74834L100
—	IDENIX PHARMACEUTICALS INC	5,050,100	$30,200	11.3%	$5.98	—	COM	45166R204
—	VIVUS INC	2,573,943	$23,371	8.8%	$9.08	—	COM	928551100
MRK	MERCK & CO INC NEW	400,000	$20,020	7.5%	$31.29	0.0%	COM	58933Y105
—	MALLINCKRODT PUB LTD CO	280,000	$14,633	5.5%	$52.26	—	SHS	G5785G107
BMY	BRISTOL MYERS SQUIBB CO	250,000	$13,288	5.0%	$34.16	0.0%	COM	110122108
ABBV	ABBVIE INC	250,000	$13,203	4.9%	$30.39	0.0%	COM	00287Y109
PFE	PFIZER INC	410,000	$12,558	4.7%	$17.62	0.0%	COM	717081103
—	REPROS THERAPEUTICS INC	459,508	$8,409	3.1%	$18.30	—	COM NEW	76028H209
—	BIO-REFERENCE LABS INC	285,300	$7,287	2.7%	$25.54	—	COM $.01 NEW	09057G602
—	AVEO PHARMACEUTICALS	2,570,759	$4,730	1.8%	$1.84	—	COM	053588109